The FDA-approved semaglutide, sold under the brand name Wegovy, has been touted for its ability to help lower the risk of a heart attack, stroke or cardiovascular death, after a study published in 2023 showed that the medication lowers certain peoples risk for those events by as much as 20%
Developed in the 1990s for research, Ipamorelin is now used to help with hormone imbalances, anti-aging, and more
Short Description A comprehensive medical weight loss program that blends medication with coaching
Whether the premium is worth it depends on your concentration and vial size
She and other doctors say there are deep inequities related to who can access the drugs
Semaglutide acts solely as a GLP-1 receptor agonist, whereas tirzepatide combines the action of GLP-1 with GIP receptor agonism